EIDOS THERAPEUTICS, INC. Research and Development Expense
EIDOS THERAPEUTICS, INC. reported Research and Development Expense of $22.57 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2020-10-29
- EIDOS THERAPEUTICS, INC. research and development expense for the quarter ending 2020-09-30 was $22.57M, a 88.27% increase year-over-year.
- EIDOS THERAPEUTICS, INC. research and development expense for the quarter ending 2020-06-30 was $17.92M, a 43.43% increase year-over-year.
- EIDOS THERAPEUTICS, INC. research and development expense for the quarter ending 2020-03-31 was $17.57M, a 105.58% increase year-over-year.
- EIDOS THERAPEUTICS, INC. research and development expense for the quarter ending 2019-12-31 was $13.86M, a 66.50% increase year-over-year.
- EIDOS THERAPEUTICS, INC. research and development expense for fiscal 2019 was $46.89M, a 64.30% increase from fiscal 2018.
- EIDOS THERAPEUTICS, INC. research and development expense for fiscal 2018 was $28.54M, a 207.33% increase from fiscal 2017.
- EIDOS THERAPEUTICS, INC. research and development expense for fiscal 2017 was $9.29M, a 435.52% increase from fiscal 2016.
- EIDOS THERAPEUTICS, INC. research and development expense for fiscal 2016 was $1.73M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2020-09-30 | $22.57M 10-Q · filed 2020-10-29 | $40.49M derived: sum of 2 quarters · filed 2020-10-29 | $58.07M 10-Q · filed 2020-10-29 | $71.92M derived: sum of 4 quarters · filed 2020-10-29 | |||
| 2020-06-30 | $17.92M 10-Q · filed 2020-08-06 | $35.50M 10-Q · filed 2020-08-06 | $49.36M derived: sum of 3 quarters · filed 2020-08-06 | $61.34M derived: sum of 4 quarters · filed 2020-10-29 | |||
| 2020-03-31 | $17.57M 10-Q · filed 2020-05-08 | $31.43M derived: sum of 2 quarters · filed 2020-05-08 | $43.42M derived: sum of 3 quarters · filed 2020-10-29 | $55.92M derived: sum of 4 quarters · filed 2020-10-29 | |||
| 2019-12-31 | $13.86M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $25.84M derived: sum of 2 quarters · filed 2020-10-29 | $38.34M derived: sum of 3 quarters · filed 2020-10-29 | $46.89M 10-K · filed 2020-02-26 | |||
| 2019-09-30 | $11.99M 10-Q · filed 2020-10-29 | $24.48M derived: sum of 2 quarters · filed 2020-10-29 | $33.03M 10-Q · filed 2020-10-29 | $41.36M derived: sum of 4 quarters · filed 2020-10-29 | |||
| 2019-06-30 | $12.50M 10-Q · filed 2020-08-06 | $21.05M 10-Q · filed 2020-08-06 | $29.37M derived: sum of 3 quarters · filed 2020-08-06 | $37.74M derived: sum of 4 quarters · filed 2020-08-06 | |||
| 2019-03-31 | $8.55M 10-Q · filed 2020-05-08 | $16.87M derived: sum of 2 quarters · filed 2020-05-08 | $25.24M derived: sum of 3 quarters · filed 2020-05-08 | $31.44M derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2018-12-31 | $8.32M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $16.69M derived: sum of 2 quarters · filed 2020-02-26 | $22.89M derived: sum of 3 quarters · filed 2020-02-26 | $28.54M 10-K · filed 2020-02-26 | |||
| 2018-09-30 | $8.37M 10-Q · filed 2019-10-31 | $7.93M 10-Q · filed 2018-11-06 | $14.56M derived: sum of 2 quarters · filed 2019-10-31 | $20.22M 10-Q · filed 2019-10-31 | $21.36M 10-Q · filed 2018-11-06 | $23.92M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2018-06-30 | $6.20M 10-Q · filed 2019-08-01 | $7.40M 10-Q · filed 2018-08-07 | $11.85M 10-Q · filed 2019-08-01 | $13.43M 10-Q · filed 2018-08-07 | $15.55M derived: sum of 3 quarters · filed 2020-02-26 | $17.83M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2018-03-31 | $5.65M 10-Q · filed 2019-05-07 | $9.36M derived: sum of 2 quarters · filed 2020-02-26 | $11.64M derived: sum of 3 quarters · filed 2020-02-26 | $12.90M derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2017-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $5.99M derived: sum of 2 quarters · filed 2020-02-26 | $7.25M derived: sum of 3 quarters · filed 2020-02-26 | $9.29M 10-K · filed 2020-02-26 | |||
| 2017-09-30 | $2.28M 10-Q · filed 2018-11-06 | $3.54M derived: sum of 2 quarters · filed 2018-11-06 | $5.58M 10-Q · filed 2018-11-06 | ||||
| 2017-06-30 | $1.26M 10-Q · filed 2018-08-07 | $3.30M 10-Q · filed 2018-08-07 | |||||
| 2016-12-31 | $1.73M 10-K · filed 2019-04-15 |